Daily Briefing
Saturday, February 14, 2026
The Vibe
Healthcare AI is moving from proof-of-concept to real money and real deployment. Anterior just raised $40M to automate care approvals with AI that cuts weeks down to minutes [1], while researchers are building RAG systems for drug safety using actual FDA databases [2]. The shift from "can AI do this?" to "how fast can we scale it?" is accelerating.
Research
•RAG-based large language model achieves strong performance predicting drug-induced liver injury using FDA's Livertox database, offering a more practical approach to pharmacovigilance than traditional rule-based systems [2]
•Machine learning models successfully predict chronic postsurgical pain after video-assisted thoracoscopic surgery, with domain-specific predictor features outperforming generic approaches [3]
•Deep learning model demonstrates multicenter validation for ovarian tumor classification on CT imaging, though performance metrics vary significantly across participating sites [4]
•NICU mortality prediction model RAMA shows promise for acute kidney injury risk stratification in premature infants, addressing a critical gap in pediatric intensive care [5]
Clinical Practice & Ops
•Anterior secured $40M Series B to expand its AI platform that automates health plan administrative work, reducing care approval times from weeks to minutes across multiple payers [1]
•Hospital operations finished 2025 on solid ground with steady margins and volumes, though analysts warn of deteriorating payer mix and rising bad debt heading into 2026 [6]
Industry & Products
•FDA cleared Labcorp's launch of Roche's Alzheimer's blood test for primary care physicians to rule out disease in patients 55+ with cognitive decline symptoms [7]
•Encora Therapeutics received FDA clearance for a wearable wrist device treating essential tremor, expanding non-invasive treatment options for millions of affected Americans [8]
•NIH halted the Xarelto arm of a phase 3 stroke prevention trial due to safety concerns and lack of efficacy, marking another setback for the anticoagulant [9]
One to Watch
Monitor how quickly Anterior's $40M scales beyond care approvals — if their AI can handle complex clinical workflows reliably, every health plan will want this technology deployed within 12 months.